CHANGE PI INCLUDE DIAGNOSTIC TO INCLUDE SAR COV-2 SBIR PHASE II REMOTE DIAGNOSTIC READER

The research proposed here will support seroprevalence studies of SARS CoV-2 antibodies by the use of a rapid test system that can perform multiplexed analyses from remote point-of-care sites and transmit results to a centralized database. A drop of blood is collected from the subject’s fingertip, inserted into the cassette, and the assay is initiated by pressing a button. The assay cassette is inserted into the smartphone reader to scan the unique bar code and process the results from the suspected COVID-19 blood specimen. The availability of these infection test results from distributed collection sites that can be uploaded to a centralized database will enhance infection control measures and the medical mission of first responders. The project will be performed by the continuing efforts of the research team from Now Diagnostics and the Geneva Foundation.